TRT & Kidney Health: Impact on Renal Function

Written by Adam Maggio | Medically reviewed by Dr. Mitchell Ross, MD, ABAARM

Low testosterone is common in men with chronic kidney disease (CKD) and can worsen outcomes. TRT may improve renal function markers and overall health in these patients, but requires careful monitoring due to potential side effects.

TRT and Kidney Health: Impact on Renal Function

The kidneys are vital organs, filtering waste products from the blood, regulating blood pressure, and producing hormones. Chronic Kidney Disease (CKD) is a progressive condition that often coexists with hypogonadism in men. While the relationship is complex, emerging research suggests that Testosterone Replacement Therapy (TRT) can play a beneficial role in kidney health for hypogonadal men, though careful consideration and monitoring are paramount.

Low testosterone is highly prevalent in men with CKD, with studies indicating that up to 50% of men with advanced kidney disease experience hypogonadism. This deficiency contributes to a range of symptoms, including fatigue, muscle wasting, anemia, and reduced quality of life, which can further exacerbate the challenges of CKD. The mechanisms linking low testosterone and CKD are bidirectional: kidney dysfunction can impair testosterone production, and low testosterone can, in turn, negatively impact renal function and overall metabolic health.

Recent studies have shown that TRT in hypogonadal men with CKD can lead to improvements in several parameters. For instance, long-term testosterone therapy has been associated with improved renal function in hypogonadal men, with some studies suggesting a potential to delay the progression of CKD (Alwani et al., 2021). Benefits often include increased lean body mass, improved anemia (reducing the need for erythropoietin-stimulating agents), enhanced energy levels, and better quality of life.

The positive effects of TRT on kidney health are likely mediated through several pathways. By increasing muscle mass, TRT can improve overall metabolic health and reduce inflammation, both of which are beneficial for kidney function. Furthermore, testosterone may have direct effects on renal hemodynamics and cellular processes within the kidney. Unlike medications that only address symptoms, TRT aims to restore a fundamental hormonal balance that supports systemic health, including renal function.

However, the use of TRT in men with CKD is not without considerations. The TRAVERSE trial, while reassuring for cardiovascular safety, noted a slight increase in acute kidney injury in the testosterone group (Lincoff et al., 2023). This highlights the need for careful patient selection and vigilant monitoring of renal function, electrolytes, and hematocrit levels. It is crucial to ensure that TRT is administered at physiological doses and that patients are regularly assessed for any adverse effects.

It is important to distinguish between the potential benefits of TRT in hypogonadal men with CKD and the use of supraphysiological doses of androgens, which can be detrimental to kidney health. The goal of TRT is to normalize testosterone levels, not to exceed them. For example, while some older androgen therapies were used to treat anemia in renal disease, modern TRT focuses on restoring physiological balance.

In clinical practice, we often encounter men with CKD who are suffering from the debilitating symptoms of hypogonadism. A 60-year-old patient with Stage 3 CKD and a total testosterone of 190 ng/dL might experience significant improvements in fatigue and muscle strength within 6-12 months of carefully managed TRT. We ensure close collaboration with nephrologists to monitor kidney function and adjust dosages as needed, prioritizing patient safety.

The practical takeaway is that for hypogonadal men with chronic kidney disease, TRT can offer significant benefits in improving symptoms, body composition, and potentially renal function. However, due to the complexity of CKD, TRT must be initiated and managed with extreme caution and close monitoring by a physician experienced in both endocrinology and nephrology. Regular assessment of kidney function, blood pressure, and hematocrit is essential to ensure safe and effective treatment, making it a nuanced but potentially rewarding therapeutic option.